Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Biote (BTMD) EBIT (2021 - 2025)

Biote (BTMD) has 3 years of EBIT data on record, last reported at $5.5 million in Q4 2023.

  • For Q4 2023, EBIT fell 24.58% year-over-year to $5.5 million; the TTM value through Dec 2023 reached $28.7 million, up 147.19%, while the annual FY2024 figure was $213000.0, 99.26% down from the prior year.
  • EBIT reached $5.5 million in Q4 2023 per BTMD's latest filing, down from $7.6 million in the prior quarter.
  • Across five years, EBIT topped out at $15.4 million in Q4 2021 and bottomed at -$85.6 million in Q2 2022.
  • Average EBIT over 3 years is $208000.0, with a median of $7.7 million recorded in 2022.
  • The widest YoY moves for EBIT: up 9150.29% in 2022, down 934.34% in 2022.
  • A 3-year view of EBIT shows it stood at $15.4 million in 2021, then crashed by 52.66% to $7.3 million in 2022, then fell by 24.58% to $5.5 million in 2023.
  • Per Business Quant database, its latest 3 readings for EBIT were $5.5 million in Q4 2023, $7.6 million in Q3 2023, and $7.7 million in Q2 2023.